Concepedia

A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine

Paul Winner, Marielle A. Kabbouche, Marcy Yonker, Veronica Wangsadipura, Arlene Lum, Mitchell F. Brin

Headache The Journal of Head and Face Pain · 2020 · 49 citations · 27 references

DOIFull text

Open access

Abstract

Although this study did not meet its efficacy endpoints, onabotulinumtoxinA was well tolerated in this adolescent population. Given previous data demonstrating the benefits of onabotulinumtoxinA in adults with CM, additional studies with design modifications, including adequate statistical power, to assess the efficacy of multiple treatment cycles of onabotulinumtoxinA for CM prevention in adolescents may be informative.

References

27

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Theo Vos, Amanuel Alemu Abajobir, Kalkidan Hassen Abate et al. · The Lancet · 2017 · 13.3K citations · Full text

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

Cephalalgia · 2018 · 10.1K citations · Full text

, , +17

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse et al. · Headache The Journal of Head and Face Pain · 2010 · 957 citations

Cutaneous allodynia in the migraine population

Richard B. Lipton, Marcelo E. Bigal, Sait Ashina et al. · Annals of Neurology · 2007 · 574 citations · Full text

Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study

Dawn C. Buse, Aubrey Manack, Kristina M. Fanning et al. · Headache The Journal of Head and Face Pain · 2012 · 533 citations